 |
|
Effects of Quality Improvement Strategies for Type 2 Diabetes on Glycemic Control
A Meta-Regression Analysis
Kaveh G. Shojania, MD;
Sumant R. Ranji, MD;
Kathryn M. McDonald, MM;
Jeremy M. Grimshaw, MBChB, PhD;
Vandana Sundaram, MPH;
Robert J. Rushakoff, MD;
Douglas K. Owens, MD, MS
JAMA. 2006;296:427-440.
Context There have been numerous reports of interventions designed to improve the care of patients with diabetes, but the effectiveness of such interventions is unclear.
Objective To assess the impact on glycemic control of 11 distinct strategies for quality improvement (QI) in adults with type 2 diabetes.
Data Sources and Study Selection MEDLINE (1966-April 2006) and the Cochrane Collaboration's Effective Practice and Organisation of Care Group database, which covers multiple bibliographic databases. Eligible studies included randomized or quasi-randomized controlled trials and controlled before-after studies that evaluated a QI intervention targeting some aspect of clinician behavior or organizational change and reported changes in glycosylated hemoglobin (HbA1c) values.
Data Extraction Postintervention difference in HbA1c values were estimated using a meta-regression model that included baseline glycemic control and other key intervention and study features as predictors.
Data Synthesis Fifty randomized controlled trials, 3 quasi-randomized trials, and 13 controlled before-after trials met all inclusion criteria. Across these 66 trials, interventions reduced HbA1c values by a mean of 0.42% (95% confidence interval [CI], 0.29%-0.54%) over a median of 13 months of follow-up. Trials with fewer patients than the median for all included trials reported significantly greater effects than did larger trials (0.61% vs 0.27%, P = .004), strongly suggesting publication bias. Trials with mean baseline HbA1c values of 8.0% or greater also reported significantly larger effects (0.54% vs 0.20%, P = .005). Adjusting for these effects, 2 of the 11 categories of QI strategies were associated with reductions in HbA1c values of at least 0.50%: team changes (0.67%; 95% CI, 0.43%-0.91%; n = 26 trials) and case management (0.52%; 95% CI, 0.31%-0.73%; n = 26 trials); these also represented the only 2 strategies conferring significant incremental reductions in HbA1c values. Interventions involving team changes reduced values by 0.33% more (95% CI, 0.12%-0.54%; P = .004) than those without this strategy, and those involving case management reduced values by 0.22% more (95% CI, 0.00%-0.44%; P = .04) than those without case management. Interventions in which nurse or pharmacist case managers could make medication adjustments without awaiting physician authorization reduced values by 0.80% (95% CI, 0.51%-1.10%), vs only 0.32% (95% CI, 0.14%-0.49%) for all other interventions (P = .002).
Conclusions Most QI strategies produced small to modest improvements in glycemic control. Team changes and case management showed more robust improvements, especially for interventions in which case managers could adjust medications without awaiting physician approval. Estimates of the effectiveness of other specific QI strategies may have been limited by difficulty in classifying complex interventions, insufficient numbers of studies, and publication bias.
Author Affiliations: Ottawa Health Research Institute and Department of Medicine (Drs Shojania and Grimshaw) and Institute of Population Health (Dr Grimshaw), University of Ottawa, Ottawa, Ontario; Department of Medicine (Drs Ranji and Rushakoff) and Division of Endocrinology (Dr Rushakoff), University of California, San Francisco; and Center for Primary Care and Outcomes Research, Stanford University (Mss McDonald and Sundaram and Dr Owens) and VA Palo Alto Health Care System (Ms Sundaram and Dr Owens), Palo Alto, Calif.
RELATED LETTERS
Quality Improvement Strategies for Type 2 Diabetes
Sarah L. Krein, Sandeep Vijan, Hae Mi Choe, and Rodney A. Hayward
JAMA. 2006;296(22):2680.
EXTRACT
| FULL TEXT
Quality Improvement Strategies for Type 2 Diabetes
Michael Pignone and Darren DeWalt
JAMA. 2006;296(22):2680-2681.
EXTRACT
| FULL TEXT
Quality Improvement Strategies for Type 2 Diabetes—Reply
Kaveh G. Shojania, Sumant R. Ranji, Kathryn M. McDonald, Jeremy M. Grimshaw, Robert J. Rushakoff, and Douglas K. Owens
JAMA. 2006;296(22):2681.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
When More Is Not Better: Treatment Intensification Among Hypertensive Patients With Poor Medication Adherence
Heisler et al.
Circulation 2008;117:2884-2892.
ABSTRACT
| FULL TEXT
The Potential of Group Visits in Diabetes Care
Davis et al.
Clin. Diabetes 2008;26:58-62.
ABSTRACT
| FULL TEXT
Texas-Mexico Border Intervention by Promotores for Patients With Type 2 Diabetes
Sixta and Ostwald
The Diabetes Educator 2008;34:299-309.
ABSTRACT
| FULL TEXT
Schizophrenia Host Vulnerability and Risk of Metabolic Disturbances During Treatment with Antipsychotics
Buckley et al.
Focus 2008;6:172-179.
ABSTRACT
| FULL TEXT
The Art and Science of Diabetes Education: A Culture Out of Balance
Anderson and Funnell
The Diabetes Educator 2008;34:109-117.
ABSTRACT
| FULL TEXT
Trends in A1C Concentrations Among U.S. Adults With Diagnosed Diabetes From 1999 to 2004
Ford et al.
Diabetes Care 2008;31:102-104.
FULL TEXT
Standards of Medical Care in Diabetes--2008
American Diabetes Association
Diabetes Care 2008;31:S12-S54.
FULL TEXT
Interactive Behavior Change Technology to Support Diabetes Self-Management: Where do we stand?
Piette
Diabetes Care 2007;30:2425-2432.
FULL TEXT
Sensitivity of Patient Outcomes to Pharmacist Interventions. Part I: Systematic Review and Meta-Analysis in Diabetes Management
Machado et al.
The Annals of Pharmacotherapy 2007;41:1569-1582.
ABSTRACT
| FULL TEXT
The Tension between Needing to Improve Care and Knowing How to Do It
Auerbach et al.
NEJM 2007;357:608-613.
FULL TEXT
A Cluster-Randomized Trial of Benchmarking and Multimodal Quality Improvement to Improve Rates of Survival Free of Bronchopulmonary Dysplasia for Infants With Birth Weights of Less Than 1250 Grams
Walsh et al.
Pediatrics 2007;119:876-890.
ABSTRACT
| FULL TEXT
Measuring Progress Toward Achieving Hemoglobin A1c Goals in Diabetes Care: Pass/Fail or Partial Credit
Pogach et al.
JAMA 2007;297:520-523.
FULL TEXT
Specialists versus generalists in the era of pay for performance: "A plague o' both your houses!"
Aron and Pogach
Qual Saf Health Care 2007;16:3-5.
FULL TEXT
Review: case management and team changes are particularly effective strategies for reducing HbA1c concentrations in type 2 diabetes
Upchurch
Evid. Based Nurs. 2007;10:25-25.
FULL TEXT
Development and Evolution of a Primary Care-Based Diabetes Disease Management Program
Malone et al.
Clin. Diabetes 2007;25:31-35.
FULL TEXT
Quality Improvement Strategies for Type 2 Diabetes
Krein et al.
JAMA 2006;296:2680-2680.
FULL TEXT
Quality Improvement Strategies for Type 2 Diabetes
Pignone and DeWalt
JAMA 2006;296:2680-2681.
FULL TEXT
Other articles noted
Evid. Based Med. 2006;11:191-192.
FULL TEXT
|
